In Italy, the forecasted sales of non-steroidal anti-inflammatory and antirheumatic medicines see a steady increase from 2024 to 2028, with values rising from 4.8 to 5.3 US Dollars PPP per capita. In 2023, sales stood at an estimated 4.7 US Dollars PPP per capita.
Year-on-year growth is consistent, with increments of approximately 2% observed annually. The five-year compound annual growth rate (CAGR) is approximately 2.44%, indicating a stable upward trajectory in demand.
Future trends to watch for include:
- Innovations in drug formulations enhancing preventive care.
- A growing geriatric population potentially increasing demand.
- Healthcare policies impacting prescription frequency and pricing strategies.
